找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Combination Treatment in Autoimmune Diseases; W. B. Harrison,B. A. C. Dijkmans Book 2002 Springer-Verlag Berlin Heidelberg 2002 Autoimmune

[复制链接]
查看: 34151|回复: 52
发表于 2025-3-21 19:43:44 | 显示全部楼层 |阅读模式
书目名称Combination Treatment in Autoimmune Diseases
编辑W. B. Harrison,B. A. C. Dijkmans
视频video
图书封面Titlebook: Combination Treatment in Autoimmune Diseases;  W. B. Harrison,B. A. C. Dijkmans Book 2002 Springer-Verlag Berlin Heidelberg 2002 Autoimmune
描述W. B. Harrison, B. A. C. Dijkmans During the last decade intervention has been instituted for all kinds of disease- even in a premorbid state, as early as possible, to control the activity of the disease, to avoid further damage and to maintain quality of life. Apart from the principle ‘Treat now, not later", emphasis is laid on aggressive initial therapy. These adagia have influenced in recent times all fields of medicine, from oncology to infectious diseases and also - the topic of the present edition - the "autoimmune diseases". As an example of the latter, rheumatoid arthritis (RA) demonstrates how the attitude of physicians has been changed. From an expectant point of view in the eighties (primum nil nocere) the attitude has been changed, as we approached and entered the new millennium, to initial ag­ gressive therapy especially in patients with a poor prognosis. Despite the advance of instituting monotherapy with a single optimised disease-modifying anti-rheumatic drug (DMARD) - with methotrexate as prototype agent in RA - adequate disease re­ mission is not often achieved, and adverse events may well prevent the use of higher dosages of the single agent in question. Therefor
出版日期Book 2002
关键词Autoimmune diseases; Sjögren‘s syndrome; autoimmune disease; cell; diseases; erythematosus; immunotherapy;
版次1
doihttps://doi.org/10.1007/978-3-662-04759-0
isbn_softcover978-3-642-07704-3
isbn_ebook978-3-662-04759-0
copyrightSpringer-Verlag Berlin Heidelberg 2002
The information of publication is updating

书目名称Combination Treatment in Autoimmune Diseases影响因子(影响力)




书目名称Combination Treatment in Autoimmune Diseases影响因子(影响力)学科排名




书目名称Combination Treatment in Autoimmune Diseases网络公开度




书目名称Combination Treatment in Autoimmune Diseases网络公开度学科排名




书目名称Combination Treatment in Autoimmune Diseases被引频次




书目名称Combination Treatment in Autoimmune Diseases被引频次学科排名




书目名称Combination Treatment in Autoimmune Diseases年度引用




书目名称Combination Treatment in Autoimmune Diseases年度引用学科排名




书目名称Combination Treatment in Autoimmune Diseases读者反馈




书目名称Combination Treatment in Autoimmune Diseases读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:20:11 | 显示全部楼层
发表于 2025-3-22 02:54:48 | 显示全部楼层
发表于 2025-3-22 08:20:44 | 显示全部楼层
发表于 2025-3-22 10:01:36 | 显示全部楼层
发表于 2025-3-22 14:01:31 | 显示全部楼层
发表于 2025-3-22 19:12:40 | 显示全部楼层
A Survey of IoT Software Platformsincluding RA and osteoarthritis, was nearly $65 billion. Accordingly, the impact of RA and osteoarthritis on resource utilization is enormous [130]. The total yearly direct costs for RA alone in the United States, based on a national community-based sample, are estimated to be $15 billion [130].
发表于 2025-3-23 00:41:51 | 显示全部楼层
Advances in Conceptual Modelinging B cell lymphoproliferative disorders. The correct diagnosis requires evaluation by various specialists [35]. Differential diagnosis includes adverse effects of drugs, chronic viral infection, e.g., hepatitis C virus (HCV) and HIV, sarcoidosis, lipoproteinemias, amyloidosis, lymphomas and age-related glandular degeneration [12].
发表于 2025-3-23 03:24:02 | 显示全部楼层
Alberto Esteban,Alejandro Maté,Juan Trujillo of diseases. Patients may have more than one symptom at the same time or at different moments during life. A positive family history is an important hallmark of SpA, and reflects its genetic background.
发表于 2025-3-23 09:35:05 | 显示全部楼层
Combination therapy for autoimmune diseases: the rheumatoid arthritis modelincluding RA and osteoarthritis, was nearly $65 billion. Accordingly, the impact of RA and osteoarthritis on resource utilization is enormous [130]. The total yearly direct costs for RA alone in the United States, based on a national community-based sample, are estimated to be $15 billion [130].
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 09:35
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表